In contrast, recipients of TCDBM mixed with Itk-/- CD4+ T cells had greatly reduced mortality and clinical scores (Supplementary Figure 1B), indicating that CD4+ T cell-intrinsic ITK signaling can contribute to the severity of GVHD. This evidence concerns the gene ITK and graft versus host disease.